RC
Roundview Capital Portfolio holdings
AUM
$1.5B
1-Year Return
16.05%
This Quarter Return
+8.09%
1 Year Return
+16.05%
3 Year Return
+68.13%
5 Year Return
+112.34%
10 Year Return
+245.5%
AUM
$876M
AUM Growth
+$84.3M
(+11%)
Cap. Flow
+$31.5M
Cap. Flow
% of AUM
3.59%
Top 10 Holdings %
Top 10 Hldgs %
27.39%
Holding
297
New
27
Increased
142
Reduced
87
Closed
8
Top Buys
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$6.54M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$6.41M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
$5.78M |
| 4 |
Vanguard Intermediate-Term Bond ETF
BIV
|
$4.1M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
$2.65M |
Top Sells
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
$5.57M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
$3.1M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
$2.8M |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
$2.49M |
| 5 |
McKesson
MCK
|
$1.75M |
Sector Composition
| 1 | Financials | 14.21% |
| 2 | Technology | 11.71% |
| 3 | Healthcare | 8.8% |
| 4 | Consumer Discretionary | 6.31% |
| 5 | Industrials | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
AT&T
T
$212B
| $325K | 0.04% |
17,671
-1,153
| -6% | -$21.2K |
|
252
Philip Morris
PM
$251B
| $321K | 0.04% |
3,172
+664
| +26% | +$67.2K |
|
|
SAGE
253
DELISTED
Sage Therapeutics
SAGE
| $315K | 0.04% |
+8,260
| New | +$315K |
|
254
Align Technology
ALGN
$10.1B
| $313K | 0.04% |
+1,486
| New | +$313K |
|
255
CVS Health
CVS
$93.6B
| $313K | 0.04% |
3,358
-184
| -5% | -$17.1K |
|
256
Invesco FTSE RAFI US 1000 ETF
PRF
$8.11B
| $311K | 0.04% |
10,025
| – | – |
|
257
Clorox
CLX
$15.5B
| $297K | 0.03% |
2,113
-196
| -8% | -$27.5K |
|
258
TransDigm Group
TDG
$71.6B
| $288K | 0.03% |
457
+23
| +5% | +$14.5K |
|
259
Nuveen Municipal Value Fund
NUV
$1.82B
| $287K | 0.03% |
33,324
| – | – |
|
260
Corteva
CTVA
$49.1B
| $279K | 0.03% |
4,741
| – | – |
|
261
iShares Russell 2000 ETF
IWM
$67.8B
| $273K | 0.03% |
1,568
+30
| +2% | +$5.23K |
|
262
Intel
INTC
$107B
| $273K | 0.03% |
10,341
-1,441
| -12% | -$38.1K |
|
263
iShares MSCI South Korea ETF
EWY
$5.22B
| $271K | 0.03% |
4,796
-100
| -2% | -$5.65K |
|
264
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$3.04B
| $267K | 0.03% |
+13,266
| New | +$267K |
|
265
Schwab US Large-Cap Growth ETF
SCHG
$48.4B
| $266K | 0.03% |
19,164
| – | – |
|
266
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $264K | 0.03% |
+6,962
| New | +$264K |
|
267
Linde
LIN
$220B
| $262K | 0.03% |
+802
| New | +$262K |
|
268
Vanguard Mega Cap Growth ETF
MGK
$29.1B
| $261K | 0.03% |
1,517
-345
| -19% | -$59.3K |
|
269
iShares Core S&P Small-Cap ETF
IJR
$86B
| $260K | 0.03% |
2,745
+284
| +12% | +$26.9K |
|
270
Wabtec
WAB
$33B
| $258K | 0.03% |
2,587
-275
| -10% | -$27.4K |
|
271
Duke Energy
DUK
$93.8B
| $258K | 0.03% |
+2,501
| New | +$258K |
|
272
Vanguard Tax-Exempt Bond Index Fund
VTEB
$38.3B
| $248K | 0.03% |
5,021
-150
| -3% | -$7.42K |
|
273
Axon Enterprise
AXON
$57.2B
| $241K | 0.03% |
1,453
-2,458
| -63% | -$408K |
|
274
Tandem Diabetes Care
TNDM
$850M
| $240K | 0.03% |
+5,344
| New | +$240K |
|
275
InMode
INMD
$947M
| $239K | 0.03% |
+6,687
| New | +$239K |
|